Related Experiment Video
Updated: Jul 11, 2026
04:30
Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Calcific aortic stenosis and statin therapy: a new insight
International Journal of Cardiology
|September 11, 2007
Summary
Statin therapy may help prevent restenosis after balloon aortic valvuloplasty. This approach could benefit patients awaiting heart valve replacement, leveraging similarities between calcific aortic stenosis and atherosclerosis.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Translational Science
Background:
- Calcific aortic stenosis (CAS) shares molecular pathways with atherosclerosis.
- Balloon aortic valvuloplasty (BAV) is a palliative procedure for severe CAS.
- Restenosis after BAV necessitates further intervention, often valve replacement.
Discussion:
- Molecular similarities suggest shared therapeutic targets between CAS and atherosclerosis.
- Statins are a cornerstone therapy for atherosclerosis, targeting lipid metabolism and inflammation.
- Investigating statin use post-BAV aligns with established cardiovascular pharmacotherapy.
Key Insights:
- Statin therapy demonstrates potential to mitigate restenosis following BAV.
- Early intervention with statins could delay the need for percutaneous heart valve implantation.
- This strategy warrants clinical investigation in patients undergoing BAV.
Outlook:
- Further clinical trials are needed to confirm the efficacy of statins in preventing BAV restenosis.
- Exploring specific statin regimens and patient selection criteria will be crucial.
- This approach may offer a novel strategy to improve long-term outcomes in CAS patients.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...